In Alzheimer’s disease studies, RVG peptides expressed together with the exosome membrane surface protein Lamp2b effectively introduced targeted delivery of BACE1 siRNA into the mouse brain, with gene-silencing effects (30). The gene discussed is BACE1; the disease is early-onset autosomal dominant Alzheimer disease.